Results 61 to 70 of about 897,555 (284)

Rewriting Tumor Immunity With Bacterial Membrane Vesicles: A Versatile and Potent Therapeutic Strategy

open access: yesAdvanced NanoBiomed Research, EarlyView.
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi   +6 more
wiley   +1 more source

Prevalence of Extensively and Pan-drug-resistant Acinetobacter spp. in Nosocomial Infections in Western Saudi Arabia

open access: yesJournal of Pure and Applied Microbiology
Multidrug resistance patterns of Acinetobacter spp. have led to their emergence as an important source of nosocomial infections. This study investigated the prevalence and clinical characteristics of Acinetobacter spp.
Hanan S. Al-Ghamdi   +8 more
doaj   +1 more source

Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania. [PDF]

open access: yes, 2009
\ud Antimicrobial resistance is fast becoming a global concern with rapid increases in multidrug-resistant Gram negative organisms. The prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates increases the burden on implementing
Kamugisha, Erasmus   +19 more
core   +1 more source

Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2014
ABSTRACT The role of Acinetobacter nosocomialis and Acinetobacter pittii , which belong to the A. calcoaceticus - A. baumannii complex, in hospital-acquired infections is increasingly recognized. Here we describe a retrospective cohort
Sarunyou, Chusri   +6 more
openaire   +2 more sources

Effects of Dietary Mannan Oligosaccharides on Growth, Disease Resistance, and Gut Microbiota in Zebrafish

open access: yesAnimal Research and One Health, EarlyView.
Supplementation with mannan oligosaccharides (MOS) enhances growth, disease resistance, antioxidant capacity, and gut microbiota diversity while suppressing inflammation, apoptosis, and strengthening intestinal barrier integrity in zebrafish challenged with LPS or DSS.
Zhiyuan Lu   +4 more
wiley   +1 more source

The Rise in Carbapenem-Resistant Acinetobacter baumannii and the Emergence of Eravacycline as a Treatment Strategy: A Narrative Review

open access: yesPathogens
Acinetobacter baumannii is a significant pathogen of hospital-acquired infections, and its multidrug resistance (MDR) and extended drug resistance (XDR) have become increasingly severe, posing a global public health challenge.
Bo Guan   +3 more
doaj   +1 more source

Vesicle-Mediated Dendritic Cell Activation in Acinetobacter baumannii Clinical Isolate, which Contributes to Th2 Response

open access: yesJournal of Immunology Research, 2019
Acinetobacter baumannii, as a nonfermentation Gram-negative bacterium, mainly cause nosocomial infections in critically ill patients. With the widespread of multidrug-resistant Acinetobacter baumannii, the urgency of developing effective therapy options ...
Wei Cai   +9 more
doaj   +1 more source

Metal nanostructure‐coupled label‐free localized surface plasmon resonance biosensors for rapid and sensitive disease diagnosis

open access: yesBMEMat, EarlyView.
LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng   +4 more
wiley   +1 more source

Human neutrophils phagocytose and kill Acinetobacter baumannii and A. pittii

open access: yesScientific Reports, 2017
Acinetobacter baumannii is a common cause of health care associated infections worldwide. A. pittii is an opportunistic pathogen also frequently isolated from Acinetobacter infections other than those from A. baumannii.
María Lázaro-Díez   +12 more
doaj   +1 more source

Successful treatment of prosthetic joint infection with multidrug-resistant Acinetobacter species with debridement and retention: a case report

open access: yesSri Lankan Journal of Infectious Diseases, 2016
Acinetobacter spp. is mainly addressed in the entity of healthcare associated infections. The organism has developed substantial antimicrobial resistance, making treatment of infections attributed to A. baumannii more difficult to manage.
RND De Silva, SK Jayatilleke, A Perera
doaj   +1 more source

Home - About - Disclaimer - Privacy